Rocket Pharma ex-officer plans sale of 1,252 shares

ROCKET PHARMACEUTICALS, INC.

Rhea-AI Filing Summary

ROCKET PHARMACEUTICALS, INC. (RCKT) is the issuer for which a Form 144 notice has been filed relating to planned sales of common stock held for the account of former officer John Militello. The notice lists 1,252 shares of common stock held in an account at Fidelity Brokerage Services LLC as of 08/18/2026, with a stated market value of $4,233.51 and listing on NASDAQ.

The filing discloses that Militello received restricted stock vesting events of 887 shares on 08/11/2026 and 365 shares on 08/14/2026 as compensation from the issuer, and that 384 shares of common stock were sold on 05/19/2026 for $1,157.53 during the prior three months. A remark explains that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

Key Figures

Shares held: 1,252 shares Market value of held shares: $4,233.51 Restricted stock vesting 1: 887 shares +3 more

6 metrics

Shares held 1,252 shares Common stock held at Fidelity Brokerage Services LLC as of 08/18/2026

Market value of held shares $4,233.51 Stated value of 1,252 RCKT common shares as of 08/18/2026

Restricted stock vesting 1 887 shares Restricted stock vesting on 08/11/2026 as compensation from issuer

Restricted stock vesting 2 365 shares Restricted stock vesting on 08/14/2026 as compensation from issuer

Recent sale shares 384 shares Common stock sold on 05/19/2026 during past 3 months

Recent sale proceeds $1,157.53 Proceeds from sale of 384 shares on 05/19/2026

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, equity award distribution

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 08/11/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for John Militello."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for ROCKET PHARMACEUTICALS, INC. (RCKT)?

The filing reports planned and recent sales of RCKT common stock held for former officer John Militello. It discloses share amounts, dates, and that some sales relate to covering tax obligations from vested equity awards.

How many ROCKET PHARMACEUTICALS (RCKT) shares are referenced in Militello’s account?

The notice lists 1,252 shares of RCKT common stock held at Fidelity Brokerage Services LLC as of 08/18/2026, with a stated market value of $4,233.51, indicating the size of the position referenced in the Form 144.

What restricted stock vesting events for RCKT are disclosed in this Form 144?

The filing reports two restricted stock vestings from ROCKET PHARMACEUTICALS: 887 shares vested on 08/11/2026 and 365 shares vested on 08/14/2026, both categorized as compensation from the issuer.

What recent RCKT stock sale by John Militello is disclosed in the last three months?

The notice states that Militello sold 384 shares of ROCKET PHARMACEUTICALS common stock on 05/19/2026 for proceeds of $1,157.53, providing transparency about recent sales under Rule 144 during the past three months.

Why does the Form 144 mention tax obligations related to RCKT equity awards?

A remark explains that the reported sale includes an amount needed to cover a tax obligation arising from the settlement of a vested equity award distribution, linking part of the transaction directly to tax liabilities from compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 03:44 PM Accepted by SEC EDGAR 08/18/2026 - 03:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001662170
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Militello John
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1252	4233.51	109774597	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2026	Restricted Stock Vesting	Issuer			887	08/11/2026	Compensation
Common	08/14/2026	Restricted Stock Vesting	Issuer			365	08/14/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Militello 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/19/2026	384	1157.53

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John Militello.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)